Medical device maker Abiomed (Nasdaq: ABMD ) reported great results for the second quarter of fiscal 2013 today, but despite strong revenue growth, the stock took a massive 30% plunge.
In the following video, health care analysts Max Macaluso and David Williamson discuss Abiomed's earnings report and the reasons behind today's dramatic decline.
While you can certainly make huge gains -- and sometimes losses -- in the health care space, the best investing approach is to choose great companies and stick with them for the long term. In our free report "3 Stocks That Will Help You Retire Rich," we name stocks that could help you build long-term wealth and retire well, along with some winning strategies that every investor should be aware of. Click here now to keep reading.